• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Herbal Preparations of Medical Cannabis: A Vademecum for Prescribing Doctors.医用大麻草药制剂:为处方医生编写的指南。
Medicina (Kaunas). 2020 May 15;56(5):237. doi: 10.3390/medicina56050237.
2
Cannabis and cannabinoids.大麻和大麻素。
Med Lett Drugs Ther. 2016 Aug 1;58(1500):97-8.
3
Practical considerations in medical cannabis administration and dosing.医疗大麻给药和剂量方面的实际考虑因素。
Eur J Intern Med. 2018 Mar;49:12-19. doi: 10.1016/j.ejim.2018.01.004. Epub 2018 Jan 4.
4
Medical use of cannabis products: Lessons to be learned from Israel and Canada.大麻产品的医学用途:从以色列和加拿大汲取的经验教训。
Schmerz. 2016 Feb;30(1):3-13. doi: 10.1007/s00482-015-0083-4.
5
Promoting cannabis products to pharmaceutical drugs.将大麻产品推向药品。
Eur J Pharm Sci. 2019 Apr 30;132:118-120. doi: 10.1016/j.ejps.2019.02.027. Epub 2019 Mar 7.
6
A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms.一项初步对照研究,以确定全株大麻提取物是否能改善难治性神经源性症状。
Clin Rehabil. 2003 Feb;17(1):21-9. doi: 10.1191/0269215503cr581oa.
7
Cannabidiol - therapeutic and legal aspects.大麻二酚 - 治疗和法律方面。
Pharmazie. 2020 Oct 1;75(10):463-469. doi: 10.1691/ph.2020.0076.
8
Medical Marijuana: Just the Beginning of a Long, Strange Trip?医用大麻:漫长奇特之旅的开端?
Phys Ther. 2017 Feb 1;97(2):239-248. doi: 10.2522/ptj.20160367.
9
Cannabinoids for Treatment of MS Symptoms: State of the Evidence.大麻素治疗多发性硬化症症状:证据现状。
Curr Neurol Neurosci Rep. 2018 Jun 19;18(8):50. doi: 10.1007/s11910-018-0859-x.
10
How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review.医用大麻作为精神障碍治疗手段的有效性和安全性如何?一项系统性综述。
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):87-105. doi: 10.1007/s00406-019-00984-4. Epub 2019 Jan 31.

引用本文的文献

1
Comparative Effects of THC and CBD on Chemotherapy-Induced Peripheral Neuropathy: Insights from a Large Real-World Self-Reported Dataset.四氢大麻酚(THC)和大麻二酚(CBD)对化疗引起的周围神经病变的比较影响:来自大型真实世界自我报告数据集的见解
Biomedicines. 2025 Aug 6;13(8):1921. doi: 10.3390/biomedicines13081921.
2
Population genomics of a natural Cannabis sativa L. collection from Iran identifies novel genetic loci for flowering time, morphology, sex and chemotyping.来自伊朗的天然大麻(Cannabis sativa L.)群体基因组学研究确定了开花时间、形态、性别和化学分型的新基因座。
BMC Plant Biol. 2025 Jan 21;25(1):80. doi: 10.1186/s12870-025-06045-4.
3
Bibliometric analysis of beneficial cannabis research: Performance analysis and science mapping from 2012 to 2022 and focus on Morocco.有益大麻研究的文献计量分析:2012年至2022年的绩效分析与科学图谱绘制及聚焦摩洛哥
Toxicol Rep. 2024 Aug 15;13:101713. doi: 10.1016/j.toxrep.2024.101713. eCollection 2024 Dec.
4
The Role of Cannabinoids in Advancing Cancer Treatment: Insights from Evidence-Based Medicine.大麻素在推进癌症治疗中的作用:基于循证医学的见解。
Curr Oncol Rep. 2024 Nov;26(11):1334-1348. doi: 10.1007/s11912-024-01589-4. Epub 2024 Aug 7.
5
Is a Low Dosage of Medical Cannabis Effective for Treating Pain Related to Fibromyalgia? A Pilot Study and Systematic Review.低剂量医用大麻对治疗纤维肌痛相关疼痛有效吗?一项初步研究与系统评价。
J Clin Med. 2024 Jul 12;13(14):4088. doi: 10.3390/jcm13144088.
6
In the weeds: A comprehensive review of cannabis; its chemical complexity, biosynthesis, and healing abilities.深入探讨:大麻的全面综述;其化学复杂性、生物合成及治疗能力
Toxicol Rep. 2024 Jun 29;13:101685. doi: 10.1016/j.toxrep.2024.101685. eCollection 2024 Dec.
7
Decoding the Postulated Entourage Effect of Medicinal : What It Is and What It Isn't.解读药用植物假定的整体效应:其内涵与非内涵
Biomedicines. 2023 Aug 21;11(8):2323. doi: 10.3390/biomedicines11082323.
8
Cannabidiol and Tetrahydrocannabinol Use in Parkinson's Disease: An Observational Pilot Study.大麻二酚和四氢大麻酚在帕金森病中的应用:一项观察性初步研究。
Cureus. 2023 Jul 24;15(7):e42391. doi: 10.7759/cureus.42391. eCollection 2023 Jul.
9
Should oncologists trust cannabinoids?肿瘤学家应该相信大麻素吗?
Front Pharmacol. 2023 Jul 13;14:1211506. doi: 10.3389/fphar.2023.1211506. eCollection 2023.
10
Acute Toxicity and Pharmacokinetic Profile of an EU-GMP-Certified L. in Rodents.欧盟药品生产质量管理规范(EU-GMP)认证的[具体名称未给出,推测为某种物质,这里用“L.”代替]在啮齿动物中的急性毒性和药代动力学特征
Pharmaceuticals (Basel). 2023 May 3;16(5):694. doi: 10.3390/ph16050694.

本文引用的文献

1
Monitoring Perinatal Exposure to Cannabis and Synthetic Cannabinoids.监测围产期接触大麻和合成大麻素。
Ther Drug Monit. 2020 Apr;42(2):194-204. doi: 10.1097/FTD.0000000000000667.
2
Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study.口服、吸食和蒸发大麻对与食欲和代谢相关的内分泌途径的影响:一项随机、双盲、安慰剂对照、人体实验室研究。
Transl Psychiatry. 2020 Feb 19;10(1):71. doi: 10.1038/s41398-020-0756-3.
3
Fast and sensitive UHPLC-MS/MS analysis of cannabinoids and their acid precursors in pharmaceutical preparations of medical cannabis and their metabolites in conventional and non-conventional biological matrices of treated individual.快速灵敏的 UHPLC-MS/MS 分析药用大麻制剂中的大麻素及其酸前体,以及在常规和非常规生物基质中经治疗个体的代谢物。
Talanta. 2020 Mar 1;209:120537. doi: 10.1016/j.talanta.2019.120537. Epub 2019 Nov 15.
4
Pharmacists and the future of cannabis medicine.药剂师与大麻药物的未来。
J Am Pharm Assoc (2003). 2020 Jan-Feb;60(1):207-211. doi: 10.1016/j.japh.2019.11.007. Epub 2019 Dec 20.
5
Medicinal cannabis in Latin America: History, current state of regulation, and the role of the pharmacist in a new clinical experience with cannabidiol oil.拉丁美洲的药用大麻:历史、当前监管状况,以及药剂师在使用大麻二酚油的新临床经验中的作用。
J Am Pharm Assoc (2003). 2020 Jan-Feb;60(1):212-215. doi: 10.1016/j.japh.2019.09.012. Epub 2019 Nov 6.
6
Acute Cannabis Toxicity.急性大麻中毒
Pediatr Emerg Care. 2019 Nov;35(11):799-804. doi: 10.1097/PEC.0000000000001970.
7
Adverse events following cannabis for medical use in Tuscany: An analysis of the Italian Phytovigilance database.托斯卡纳地区医用大麻的不良事件:意大利植物药警戒数据库分析
Br J Clin Pharmacol. 2020 Jan;86(1):106-120. doi: 10.1111/bcp.14140. Epub 2020 Jan 3.
8
Δ-Tetrahydrocannabinol Derivative-Loaded Nanoformulation Lowers Intraocular Pressure in Normotensive Rabbits.载有Δ-四氢大麻酚衍生物的纳米制剂可降低正常血压家兔的眼压。
Transl Vis Sci Technol. 2019 Sep 19;8(5):15. doi: 10.1167/tvst.8.5.15. eCollection 2019 Sep.
9
Characteristics of a Multistate Outbreak of Lung Injury Associated with E-cigarette Use, or Vaping - United States, 2019.2019 年美国与电子烟或蒸气相关的肺损伤多州暴发的特征。
MMWR Morb Mortal Wkly Rep. 2019 Oct 4;68(39):860-864. doi: 10.15585/mmwr.mm6839e1.
10
Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry.支持在精神病学中使用大麻二酚的临床前和临床证据。
Evid Based Complement Alternat Med. 2019 Aug 29;2019:2509129. doi: 10.1155/2019/2509129. eCollection 2019.

医用大麻草药制剂:为处方医生编写的指南。

Herbal Preparations of Medical Cannabis: A Vademecum for Prescribing Doctors.

机构信息

Department of Excellence of Biomedical Sciences and Public Health, "Politecnica delle Marche" University of Ancona, Via Tronto 71, 60126 Ancona, Italy.

Analytical Pharmacotoxicology Unit Head, National Centre on Addiction and Doping, Istituto Superiore di Sanità V.Le Regina Elena 299, 00161 Rome, Italy.

出版信息

Medicina (Kaunas). 2020 May 15;56(5):237. doi: 10.3390/medicina56050237.

DOI:10.3390/medicina56050237
PMID:32429074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7279290/
Abstract

Cannabis has been used for centuries for therapeutic purposes. In the last century, the plant was demonized due to its high abuse liability and supposedly insufficient health benefits. However, recent decriminalization policies and new scientific evidence have increased the interest in cannabis therapeutic potential of cannabis and paved the way for the release of marketing authorizations for cannabis-based products. Although several synthetic and standardized products are currently available on the market, patients' preferences lean towards herbal preparations, because they are easy to handle and self-administer. A literature search was conducted on multidisciplinary research databases and international agencies or institutional websites. Despite the growing popularity of medical cannabis, little data is available on the chemical composition and preparation methods of medical cannabis extracts. The authors hereby report the most common cannabis preparations, presenting their medical indications, routes of administration and recommended dosages. A practical and helpful guide for prescribing doctors is provided, including suggested posology, titration strategies and cannabinoid amounts in herbal preparations obtained from different sources of medical cannabis.

摘要

大麻被用于医疗用途已有数个世纪。在上个世纪,由于其高滥用倾向和据称不足的健康益处,该植物被妖魔化。然而,最近的非刑事化政策和新的科学证据增加了人们对大麻治疗潜力的兴趣,并为大麻类产品的营销许可铺平了道路。尽管目前市场上有几种合成的和标准化的产品,但患者更倾向于草药制剂,因为它们易于操作和自我给药。在多学科研究数据库以及国际机构或机构网站上进行了文献检索。尽管医用大麻越来越受欢迎,但有关医用大麻提取物的化学成分和制备方法的数据却很少。作者在此报告了最常见的大麻制剂,介绍了它们的医疗适应证、给药途径和推荐剂量。为处方医生提供了实用且有帮助的指南,包括建议的剂量、滴定策略以及从不同医用大麻来源获得的草药制剂中的大麻素含量。